# Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

> **NCT00702247** · PHASE2 · UNKNOWN · sponsor: **Azienda Ospedaliera San Giovanni Battista**

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Hematopoietic Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00702247
- **Lead sponsor:** Azienda Ospedaliera San Giovanni Battista
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702247, "Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00702247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*